Xeris Biopharma Holdings, Inc. (XERS)
8.18
+0.02
(+0.25%)
USD |
NASDAQ |
Sep 18, 14:46
Xeris Biopharma Holdings Price : 8.18 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 7.685 | 8.18 | 7.685 | 8.16 | 2.341M |
| Sep 16, 2026 | 7.50 | 7.92 | 7.50 | 7.78 | 2.035M |
| Sep 15, 2026 | 7.57 | 7.58 | 7.41 | 7.49 | 1.181M |
| Sep 14, 2026 | 7.595 | 7.685 | 7.52 | 7.57 | 2.006M |
| Sep 11, 2026 | 7.89 | 7.89 | 7.40 | 7.45 | 2.403M |
| Sep 10, 2026 | 7.80 | 7.99 | 7.63 | 7.67 | 1.955M |
| Sep 09, 2026 | 8.43 | 8.605 | 7.64 | 7.71 | 2.816M |
| Sep 08, 2026 | 8.39 | 8.515 | 8.22 | 8.48 | 1.355M |
| Sep 04, 2026 | 8.50 | 8.585 | 8.38 | 8.53 | 1.031M |
| Sep 03, 2026 | 8.64 | 8.775 | 8.415 | 8.59 | 1.598M |
| Sep 02, 2026 | 8.49 | 8.635 | 8.275 | 8.58 | 1.351M |
| Sep 01, 2026 | 8.42 | 8.615 | 8.38 | 8.43 | 1.144M |
| Aug 31, 2026 | 8.45 | 8.485 | 8.285 | 8.44 | 1.403M |
| Aug 28, 2026 | 8.62 | 8.675 | 8.37 | 8.48 | 1.027M |
| Aug 27, 2026 | 8.62 | 8.74 | 8.55 | 8.60 | 1.274M |
| Aug 26, 2026 | 8.74 | 8.89 | 8.61 | 8.68 | 1.504M |
| Aug 25, 2026 | 8.81 | 8.95 | 8.665 | 8.74 | 1.006M |
| Aug 24, 2026 | 8.66 | 8.80 | 8.539 | 8.74 | 870743.0 |
| Aug 21, 2026 | 8.61 | 8.81 | 8.535 | 8.70 | 1.563M |
| Aug 20, 2026 | 8.91 | 8.985 | 8.56 | 8.60 | 2.001M |
| Aug 19, 2026 | 8.93 | 9.02 | 8.77 | 8.78 | 2.250M |
| Aug 18, 2026 | 8.58 | 8.88 | 8.47 | 8.85 | 2.142M |
| Aug 17, 2026 | 8.45 | 8.545 | 8.259 | 8.52 | 1.335M |
| Aug 14, 2026 | 8.33 | 8.67 | 8.25 | 8.60 | 1.366M |
| Aug 13, 2026 | 8.59 | 8.70 | 8.30 | 8.33 | 1.852M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Zevra Therapeutics, Inc. | 11.66 |
| Aclaris Therapeutics, Inc. | 5.40 |
| ANI Pharmaceuticals, Inc. | 76.27 |
| Corcept Therapeutics, Inc. | 111.78 |
| Veru, Inc. | 2.41 |
Price Related Metrics
| PS Ratio | 4.318 |
| Price to Free Cash Flow | 26.01 |
| Earnings Yield | -1.25% |
| Market Cap | 1.420B |
| Operating PE Ratio | 39.57 |
| Normalized PE Ratio | 366.82 |